Crinetics Pharmaceuticals Inc buy UBS Group AG
Start price
02.07.26
/
50%
€36.65
Target price
02.07.27
€48.33
Performance (%)
95.74%
Price
09:06
€71.74
Summary
This prediction is currently active. With a performance of 95.74% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 02.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Crinetics Pharmaceuticals Inc | 95.74% |
| iShares Core DAX® | 4.367% |
| iShares Nasdaq 100 | -0.294% |
| iShares Nikkei 225® | -0.471% |
| iShares S&P 500 | 1.267% |
Comments by UBS_Group_AG for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (CRNX) is now covered by UBS Group AG. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat